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Abstract 
Atrial Fibrillation (AF) is known to be a significant risk factor for ischemic stroke, as well as 
other thromboembolic events.   Patients with (AF) are at increased risk of arterial 
thromboembolism.  The DNP Quality Improvement (QI) project used the screening tool 
CHA2DS2-VASc to identify AF patients who are at low, moderate, or high risk for embolic 
disease and stroke at a North Carolina primary health care setting.  This project directly impacted 
outpatient health care with achieving better care quality outcomes for the AF patient population.  
The nurse practitioner care model, which targets quality initiative care provision to patients with 
cardiovascular illnesses, provided the theoretical underpinning for this QI project in order to 
meet the goals of the Institute of Health Improvement Triple Aim.  Using CHA2DS2-VASc as a 
screening tool in this QI project helped to identify risk factors for AF patients. Of the 50 patients 
with AF screened, 82% were at moderate to high risk for stroke and met eligibility for oral 
anticoagulation therapy.  As a result, the CHAD2DS2-VASc screening tool is incorporated into 
the electronic health record ensuring adherence and sustainability. 
Keywords:  Identification, atrial fibrillation, CHA2DS2-VASc, quality improvement, risk 
factor 
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Chapter One:  Overview of the Problem 
About 49 million people 65 years and older live in the United States (United States 
Census Bureau, 2018).  This population has more atrial fibrillation (AF) and stroke than any 
other age group (Center for Disease Control and Prevention [CDC], 2017).  AF is a significant 
risk factor for ischemic stroke.  Both AF and stroke are leading health morbidity and mortalities 
in those 65 years and older.  This chapter outlined the background and significance of the 
problem of AF patients who are at risk for stroke.  With a question guiding inquiry, this chapter 
discussed the population, intervention, comparison, and outcome of the interventions for stroke.  
This chapter concludes with summarized statements. 
Background Information 
In a cross-section analysis, Rozen et al. (2018) examined in their cross‐sectional analysis 
study of emergency department (ED) visits for AF from 2007 to 2014 and noted that AF occurs 
more frequently in adults 65 and older.  Research indicates that AF caused 15–20% of ischemic 
strokes annually in the United States (CDC, 2017).  It is an independent risk factor for stroke that 
occur undetected at times, in patients 65 years and older (Turakhia et al., 2018).  According to 
Boehme, Esenwa, & Elkind (2017), about 28% of this population in the United States (US) 
suffered an ischemic stroke (Boehme, Esenwa, & Elkind, 2017) with debilitating consequences 
for the patients, healthcare system, and taxpayers.  Debilitating consequences of stroke are 
associated with memory loss, dementia, gait impairment, and functional disability (Boehme, 
Esenwa, & Elkind, 2017).  Stroke is a leading cause of death, long-term disability, reduced 
mobility, and poor quality of life in more than half of adult survivors 65 and over (CDC, 2017).   
In the US, about 750,000 hospitalizations, with mortality of about 130,000 deaths occur 
yearly among AF patients (CDC, 2017).  Whereas AF costs in the United States are about $6 
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billion each year, the resulting stroke is estimated at $34 billion each year in health care services, 
medicines, and missed days of work (Boehme, Esenwa, & Elkind, 2017). Per capita, ischemic 
stroke cost the taxpayer about $14,000 to $20,000 yearly in healthcare cost (United States 
Census Bureau, 2018).  Despite the financial and health burden of AF and stroke in the United 
States, in those ≥ 65 years, several of them have undetected and undiagnosed AF (Turakhia et al., 
2018), thereby creating a healthcare gap in this population.  Increasing trends from the aging 
U.S. population suggest that there is a need for clinical implementation of practical strategies 
directed at improving the detection and prevention of AF and Stroke (Rozen et al., 2018) among 
the ≥65 population.  
Large observational cohort studies indicate that AF, increased stroke and systemic 
embolism occur with increased morbidity and mortality if no oral anticoagulation (OAC) is 
prescribed (Morillo, Banerjee, Perel, Wood & Jouven, 2017).  In a southeastern North Carolina 
(NC) primary outpatient care clinic with 12,000 active patients, 90% are adults, and 3,279 
patients are ≥ 65 years and older.  Data revealed that this primary care practice has no 
standardized screening process to identify stroke risks in patients with AF so that therapeutic 
intervention provided to prevent stroke.  Many of these patients are at risk for thromboembolic 
disease due to unidentified stroke risks or untreated AF.  For this reason, a quality improvement 
(QI) was conducted, which aimed to identify patient risk factors for stroke in this primary care 
clinic.  The QI was conducted with an evidenced-based risk assessment and stratification 
screening tool CHA2DS2-VASc to bridge that gap in health care in the clinic (see Appendix C).  
Chart reviews and data were collected for evaluation. This project increased screening adherence 
by providers and increased identification of risk for stroke in AF patients who are ≥ 65 years.  
The QI project helped to provide intervention for stroke with OAC and lifestyle modification. 
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The Significance of Clinical Problem 
AF is one of the most common disorders of cardiac rhythms.  Virchow’s triad indicated 
that vascular dysfunction, coagulation factors, and stasis of blood in the heart vessels 
(Yamashita, 2016) lead to a thromboembolic event (see Appendix D).  Patients with AF have 
increased risk of arterial thromboembolism and ischemic stroke (Kamel, Okin, Elkind, & 
Iadecola, 2016).  According to Chen et al. (2013), AF increased the risk of stroke five-times and 
contributed to about 15% of all stroke.  AF and ischemic stroke management are complicated 
and expensive; for that reason, detection through screening and identification of risk factors 
bridges the gap in care.  As Rozen et al. (2018) discussed the clinical need to implement 
strategies to detect and prevent stroke is required.   
A primary care clinic in southeastern NC had no standardized process of identifying risk 
factors for stroke; for that reason, a quality improvement project conducted helped to bridge that 
gap in care.  The QI utilized the CHA2DS2-VASc tool, according to the Clinical Practice 
Guidelines of American Heart Association/American College of Cardiology/American Heart 
Association Task Force/Heart Rhythm Society (AHA/ACC/HRS) (January et al., 2019).   The 
tool identified risk factors in AF patients who are at low, moderate, or high risk for stroke and 
embolic disease.  The QI project recommended intervention for stroke prevention.  The use of 
the screening tool increased staff adherence to screening and identification, improved quality of 
care for the AF patient, and prevented stroke in the AF patient population.      
CHA2DS2-VASc screening tool used in the project directly increased the number of 
patients identified by stratifying stroke and thromboembolism risk.  This standardized process 
directly improved the identification of patient’s risk to prevent stroke.  The process increased 
provider adherence to screening AF patients at risk and provider compliance with using the 
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evidenced-based screening tool, CHA2DS2-VASc, according to the AHA/ACC/HRS (January et 
al., 2019).  Further, this quality improvement indirectly improved the quality of patient care.  The 
QI implemented by the DNP graduate and providers impacted patient health, satisfaction, and 
quality of life by achieving better health outcomes for AF patients at risk for stroke. 
Question Guiding Inquiry (PICO) 
Population.  The QI project targeted the healthcare providers who see patients at the 
primary care clinic, including an experienced Physician, Nurse Practitioner (NP), and Physician 
Assistant (PA).  The providers utilized the evidenced-based screening tool CHA2DS2-VASc and 
screened AF patients at risk for stroke.  In using the tool, the providers screened the patients and 
increased adherence to using the tool and screening for risk factors.  Using the tool also 
increased the identification of AF patients at risk for stroke.  In the QI project, the providers 
focused and screened all patients with a diagnosis of AF who were 65 years and older in a 
primary care clinic in southeastern NC.  The QI project improved provider screening and scoring 
of the patients for better stratification and quality intervention.   
 Intervention.  Providers received education about using the evidenced-based screening 
tool before implementation (see Appendix C).   The CHA2DS2-VASc tool improved patient 
outcomes by screening and stratifying patients' stroke risk levels for therapy intervention (Zhu, 
Xiong, & Hong, 2015).  Providers screened AF patients with questions about the risk factors and 
assigned scores of 0 to “no” and 1 to “yes.”  However, a 2 was assigned a “yes,” if the age of the 
patient was ≥ 75 years or if the patient had a prior stroke or TIA.  Providers then added the 
scores and stratified a patient at a level of either low, moderate, or high risk for stroke, which 
indicated the need for anticoagulation therapy or not (Deitelzweig, Jing, Swindle, & 
Makenbaeva, 2014). Age scored one time only.  Thus, the highest possible point scored by a 
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patient was 9.  The higher the score, the higher the percentage of the annual risk score for stroke 
(see Appendix F).  A score of 9 placed a patient at a 15.2 % annual risk of having a stroke. The 
numbers stratified as no risk for 0, low risk for a 1, moderate risk for a 2 and higher risk for any 
score ≥ 2, which required intervention with OAC according to the AHA/ACC/HRS Clinical 
Practice Guidelines (January et al., 2019).  AHA/ACC/HRS recommended that any score ≥2 
required OAC to prevent stroke thromboembolism (Deitelzweig et al., 2014).  
 Implementing the CHA2DS2-VASc tool directly increased provider adherence and 
compliance with the use of the screening tool.  Providers identified patients at risk for stroke, 
which indirectly impacted patient outcomes of better health care, patient satisfaction, and 
improved quality of life.  Providers also indirectly impacted the reduction in cost per capita 
health.   
  Comparison: CHA2DS2-VASc intervention effects were compared with patients not 
identified through the screening. The CHA2DS2-VASc is a modified version of the CHADS2 
score.  The CHA2DS2-VASc enhanced the screening by adding vascular disease, increased age 
of 65 to 74, and female sex category than the CHADS2 tool.  Further, CHA2DS2-VASc 
screened and stratified patients at a more accurate assessment of stroke risk because patients 
stratified at the low-risk score with the CHADS2 are more likely to have a thromboembolic 
event (Chen et al., 2013).  This QI project improved screening and identification of AF patient's 
risk for stroke, to prevent stroke and improve their quality of life.  The use of CHA2DS2-VASc 
in this practice will not be compared to the national benchmark because the practice does not 
have a standardized tool used, and no pre-implementation statistic was available. 
 Outcome(s).  Measurable outcomes include:(1) How many patients with AF diagnoses 
were screened and identified with CHA2DS2-VASc for low, moderate, and high-risk levels 
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based on comorbid hypertension, diabetes, previous ischemic stroke, and other factors. (2) Of 
these patients, how many required no intervention. (3) How many required recommendations for 
interventions with anticoagulation therapy.   
Summary 
          AF is a significant risk factor for stroke.  Background and significance showed that stroke 
debilitated and decreased the quality of life of patients.  Stroke is associated with a high financial 
burden for the patient, health industry, and taxpayers. Older patients, 65 years and older, are 
known to experience AF and stroke more than another age group.  In a primary care site in 
southeastern NC, AF patients were screened for risk of stroke because there was no standardized 
process or tool to screen this group.  Quality improvement was conducted using a question 
guiding instrument (PICO), which outlined the target population to be the providers in the clinic.  
Providers screened patients for risk factors with an evidenced-based risk stratification screening 
tool, CHA2DS2VASc.  Patients were stratified to a low, moderate, and high risk.  Patients who 
scored ≥2 were recommended for OAC per the AHA/ACC/HRS clinical guidelines for the 
prevention of stroke.  There were no pre-implementation data compared.  Outcome measures 
included the number of patients screened and identified by providers and the number of patients 
who received OAC recommendations. The QI project identified risk among AF patients and 
prevented ischemic events with OAC recommendations.  Staff adherence to the screening 
process during implementation helped to achieve the outcomes.  Giving appropriate 
recommendations for pharmacologic intervention reduced the incidence and mortality associated 
with thromboembolic stroke.  
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Chapter Two:  Review of the Literature Evidence 
This literature review includes a review of what is previously known about the 
CHA2DS2-VASc screening tool.  The review explores screening and intervention options for 
solutions among atrial fibrillation patients in primary care.  It reviews any gap in knowledge 
regarding the use of the screening tool CHA2DS2-VASc. A summary page concludes the 
chapter. 
Literature Appraisal Methodology  
Sampling strategies.  The first search strategy was conducted in Fall of 2018 using 
electronic databases, Cumulative Index of Nursing and Allied Health Literature (CINAHL) with 
the keywords “atrial fibrillation” and “CHA2DS2-VASc” and “nursing.”  78 articles were 
located.  Of the 78 articles, 16 were rejected for date delimitations.  Out of the remaining 62, 
fifty-eight did not meet selection criteria.  Thus, four articles were used.  Using PubMed via 
Medline, 188 articles were produced after searching with the terms “atrial fibrillation” and 
“CHA2DS2-VASc”.  The best match search yielded 12 articles.  Of the 12 articles, three articles 
were kept due to topic focus, and nine were excluded.  A new search strategy was conducted in 
summer 2019 in CINAHL using MeSH terms “atrial fibrillation,” “stroke,” and 
“CHA2DS2VASC”, which produced 179 articles.  Filters applied included timeframe of 2015 – 
2019, and the English language only.  Also, the use of MeSH terms “atrial fibrillation,” “stroke 
risk factors,” “CHA2DS2VASC risk stratification,” narrowed the search to 19 articles.  All 
articles were saved in a drive, and the abstracts were reviewed.  Of these 19 articles, fourteen 
were excluded due to focus on treatment modalities, and five full-text articles were used.  A total 
of 12 articles from 2018 and a set of searches in 2019 were selected.   
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Relevant articles found from other sources were sent to emails and utilized throughout 
the progression of the project.   
Evaluation criteria.  Articles found were peer-review articles, research studies, cohort 
studies, randomized control trials.  Inclusions were research works that studied or examined the 
different impacts of CHA2DS2-VASc stratification of stroke risk.  Exclusion criteria had designs 
that focused on oral anticoagulation (OAC) treatment modalities, or solely treatment 
interventions that were not a focus of this QI project.  A meta-analysis study, comparative 
studies, cohort studies, and peer review articles directly related to the topic were included.   All 
articles having a date of more than six years were excluded.  Language limits were exclusive to 
English.  The patient population excluded pediatrics and any patient without a diagnosis of AF.  
A PRISMA diagram that depicted a uniform reporting standard of the research data was included 
(see Appendix B).  Both quantitative and qualitative articles were included in the materials. A 
literature matrix was added using the total articles reviewed from the research (see Appendix A).  
Articles from other sources sent to the project leader’s email were screened and used.  Evidence 
from level I to VII was used (Melnyk & Fineout-Overholt, 2011).  Level I had the highest 
number as they incorporated the meta-analysis and systemic reviews with evidence that 
supported clinical practice (Black, Balneaves, Garossino, Puyat, & Qian, 2015). 
Evidence ranking included four levels I systematic reviews and meta-analysis regarding 
the abilities of CHA2DS2-VASc in the stratification of risk factors for ischemic events.   One 
level II randomized controlled trial assessed the outcome of the nurse practitioner care model on 
the quality of life of patients concerning their health (Kutzleb et al., 2015).  The project used 
two-level III, and two of level IV cohort studies, one level V systematic review, and three-level 
VII clinical expert guidelines on the use of CHA2DS2-VASc.  The one thing that the research 
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uniformly established was that AF required to be identified for intervention in other to prevent a 
thromboembolic event.   
Literature Review Findings.  
Lahewala et al. (2017) determined from a cohort review of thromboembolic risk 
assessment of AF patients in the hospital, using the CHA2DS2-VASc tool that a higher score 
was associated with increased death, more length of hospital stay, readmission and increased 
healthcare cost.  In other words, the higher the risk identified with CHA2DS2-VASc, the higher 
the mortality, morbidity, and healthcare costs for the patient and indirectly higher for the 
healthcare system and taxpayers.  Patients with AF have the most common disorder of the 
cardiac rhythm (Kamel, Okin, Elkind, & Iadecola, 2016).  Per Virchow’s triad, AF causes 
pooling of blood in the heart (Kamel et al., 2016).  This stasis increases the risk of arterial 
thromboembolism and ischemic stroke (Kamel et al., 2016).  AF contributes to about 15% of 
ischemic strokes in the United States (CDC, 2017) and is the most common cardiac arrhythmia 
(Zhu, Xiong, & Hong, 2015).   In their meta-analysis, Zhu, Xiong, and Hong (2015) agreed that 
using the validated tool CHA2DS2-VASc score, enabled the identification of AF patients at risk 
for a thromboembolic event.  Screening and identifying with the CHA2DS2-VASC directed 
provider’s therapeutic choice of anticoagulation therapy in patients with AF. This standard, as 
discussed in the findings of the above article, is not present in the primary care setting of this 
project. CHA2DS2-VASC predicted stroke and thromboembolic events in AF patients.  The tool 
helped to optimize the prescription of anticoagulation therapy (Zhu, Xiong, & Hong, 2015) for 
the prevention of stroke.   
According to Ding et al., (2017), AF was common among older adults and that although 
the use of anticoagulant drugs has increased among AF patients, two-thirds of the older AF 
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patients with a high risk of stroke are untreated, partly due to unknown risk factors.  That is why 
screening and identifying with CHA2DS2-VASc is significant in this group to bridge the gap in 
care.  Such a gap in care is one of the reasons for this project.   Bridging the gap will help to 
standardize identification through screening with the validated tool in the primary care site of the 
project.   
Chapman et al. (2017) found that adherence to clinical guidelines on the use of the risk 
stratification tool improved stroke prevention.  Adherence to clinical guidelines like the use of 
the standardized stratification tool in primary care can improve risk identification and stroke 
prevention, as indicated by the use of CHA2DS2-VASc.  An interprofessional team that included 
primary care providers for stroke prevention was important (Chapman et al., 2017).   
Smigorowsky, Norris, McMurtry, and Tsuyuki (2017) discussed the gap in timely access 
to care for atrial fibrillation patients as a concern.  They maintained that the use of nurse 
practitioner staffed primary care clinics may improve identification, access to care, and quality of 
care of AF patient population in the primary care setting.  To concur, a nurse practitioner-led 
primary care clinic may improve identification and adherence, considering the recent successful 
nursing models, and QI implemented to decrease hospital readmission and healthcare cost 
(Kutzleb et al., 2015).    
On a related note, the literature indicates several gaps in knowledge and clinical practice 
regarding the effects of CHA2DS2-VASc score and AF on the renal system, which has also led 
to a stroke.  Beyer-Westendorf, Kreutzc, Poschd, & Aye, (2017) found a strong correlation 
between the CHA2DS2-VASc scores among AF patients and lower glomerular filtration rate 
(GFR). Lower GFR indicates a decline in renal function in adults ≥ 65 years (Beyer-Westendorf 
et al., 2017).  Based on their study findings, Mohinder et al. (2017) concluded that non-valvular 
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atrial fibrillation, which presented with stroke and renal failure, is associated with a higher 
CHA2DS2-VASc score.  Although the focus of this QI is on AF as a risk factor for stroke, 
empirical work on higher CHA2DS2-VASC scores and its effects of AF on the renal system 
bears discussing. (Mohinder et al., 2017).  Mohinder et al. (2017), reported debilitating effects of 
AF on the renal system leading to stroke and correlated it with high CHA2DS2VASc score in AF 
patients.  Literature also delved into cross-sectional and repeat cohort studies that have linked AF 
to dementia, including Alzheimer’s disease, independent of the clinical valvular AF in patients 
over 55 years (Alonso, & Arenas de Larriva, 2016).  AF and dementia open a new avenue for 
knowledge in research. 
Limitations of the Literature Review Process 
Limitation of the literature review includes the English language only, which misses out 
on studies conducted in Europe, Asia, and reported in French or Japanese language.  There are a 
few versions of the risk assessment tool, including CHADS, RCHADS with different 
interpretations and applications concerning the CHA2DS2-VASc screening.  The different 
interpretations and applications of these tools limit quick understanding and use of the process.  
Despite empirical works on the debilitating health and financial costs of AF on patients, the 
healthcare system, and on the taxpayers, a gap still exists in the identification of AF patient's risk 
for stroke in primary care.  This gap exists in the clinics, whether the clinic is staffed by nurse 
practitioners or traditional physician providers (Smigorowsky, Norris, McMurtry, & Tsuyuki, 
2017).  Adherence to the use of the stratification tool lack in several primary care setting, 
including the project site and so warrants the need for a QI project.   
Since 2014, a recommendation for the use of the CHA2DS2-VASc stratification tool was 
in place.  This recommendation was for the identification of AF patient's risk for stroke in other 
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to provide an intervention, yet, most primary care clinics have gaps in the use of this tool.  There 
is, therefore, the need for quality improvement work in primary care for the use of this 
stratification tool.  Atrial fibrillation continues to be a significant health problem resulting in 
stroke and its sequelae, including renal decline, functional decline, dementia, and cognitive 
impairment.  Therefore, using the CHA2DS2-VASc tool to identify the AF patients at risk for 
stroke in this primary care site is an essential objective of this quality improvement.  Further QI 
projects are warranted in the intervention for patients identified that have a risk for stroke.   
There are new nursing model clinics and QI projects that successfully identify and 
manage high-risk patients (Kutzleb et al., 2015) outcomes in the outpatient setting.  The NP-care 
model and its program focused specifically on cardiovascular patients with heart failure who 
were discharged to home but identified to be at high-risk for early readmissions.  There is 
evidence in fields other than nursing for QI projects and models that manage outcomes for the 
AF.  However, there is no evidence for nursing models or QI projects for the identification and 
management of this AF population in the outpatient clinic, including the project site.  Therefore, 
more nurse practitioner-led clinics, QI, and evidence are needed in this area. 
Discussion 
Conclusions of findings.  CHA2DS2-VASc, as a screening tool, identified and stratified 
risk for stroke among AF patients in primary care settings.  As Smigorosky et al. (2017) wrote, 
AF patients require formal screening with tools such as CHA2DS2-VASc for identification of 
risk and stroke prevention, which may result in better health and better quality of 
life.   Successful use of CHA2DS2-VASc involved an interprofessional team, including 
physicians, nurses, nurse practitioners in primary care (Chapman et al., 2017).  The high cost of 
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six billion dollars and about 450,000 hospitalizations accumulates from AF, each year in the US 
(Cutugno, 2015) A QI project that will decrease the risk associated with AF patients and reduce 
cost in health care is advisable.  Risk factors such as diabetes mellitus, prior stroke, congestive 
heart failure, and hypertension make up the stratification scheme.  Other risk factors like age 65 
to 74 years, female gender, ≥ 75years, vascular disease including peripheral artery disease, 
myocardial infarction, and aortic plaque, make up the stratification scheme in CHA2DS2-VASc 
(Deitelzweig, Jing, Swindle, & Makenbaeva, 2014).   These risk factors are found in a significant 
number of AF patients in primary care (Jacob, 2017).  AF is a considerable risk factor for stroke 
and thromboembolic events.  Many AF patients and older adults in primary care remain at risk 
for thromboembolic disease from AF due to a lack of identification of the risk factors (Jacob, 
2017).   
The CHA2DS2-VASc screening tool is best suited to stratify AF patients into low, 
moderate, or high risk for stroke.  AF accumulates high cost to the patient, the healthcare 
industry, and taxpayers in the US.   Primary care clinics run traditionally by physicians and NP 
staffed primary care clinics will identify AF patients and provide intervention for the patients at 
risk for stroke.  A recommendation is for NP staffed clinics to identify and stratify the risk 
factors of AF patients in primary care.  This identification will improve the health of AF patients, 
by directing their interventions, improving their quality of life, and reducing health care costs 
(Lahewala, 2017), even as other NP models are successful (Kutzleb et al., 2015).   
Advantages and disadvantages of findings.  
Direct advantages that support the QI project. The direct advantages of 
CHA2DS2-VASc, as a screening tool that screens, stratifies, and identifies a patient’s risk for 
stroke.  This stratification helps intervention with medication therapy.  It guides patient 
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education on lifestyle modification for the patients at risk for stroke. Using the CHA2DS2-VASc 
screening tool will increase staff adherence to the utilization of quality improvement.  Staff will 
also adhere to the clinical practice guidelines set by the American College of 
Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the 
Heart Rhythm Society guideline (AHA/ACC/HRS) (January et al., 2019) for the AF patient 
population in primary care  
Indirect advantage. The QI project will indirectly prevent stroke and reduce comorbid 
conditions.  Indirectly, the QI will improve the care quality and patient-provider relations in the 
primary care setting.  It will also indirectly improve the quality of life of the patient population 
and save lives.  The QI will indirectly reduce systemic health costs (Lahewala, 2017).    
Disadvantage. The QI project addressed the most recent version of the stratification tool 
CHA2DS2-VASc, according to the American College of Cardiology/American Heart 
Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society guideline 
(AHA/ACC/HRS).  Despite the above, some researchers believed that the CHA2DS2-VASc 
stratification scheme exposes too many patients to the intervention of anticoagulation therapy.   
The above opinion was due to lower risk standards, which may cause hemorrhagic effects on 
them (Wang, Zhang, Liu, Zhong, & Yang, 2018).  For this reason, in the management of 
antithrombotic therapy, a recommendation is in place for a bleeding risk to be screened before 
treatment (Deering, 2017).  However, the benefits of CHA2DS2VASC in identifying risk for the 
prevention of stroke outweigh this hemorrhagic exposure risk. 
Utilization of findings in practice.  The utility of the CHA2DS2-VASc tool in primary 
care to identify AF patient’s risks for stroke is one the aim of this quality improvement 
project.  Based on the clinical guideline provided by the AHA/ACC/HRS, the patient population 
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will be screened and then stratified.  A “yes” score is equivalent to a stratified number of 1 or 2, 
while a “no” score is equivalent to zero in each of the conditions being screened.  A higher score 
indicates a higher risk of stroke, and a low score indicates a low risk of stroke.  A score of zero is 
considered an indeed lower risk score and will not require medication therapy or intervention 
(Deitelzweig, Jing, Swindle, & Makenbaeva, 2014).  A score of 0-1 is considered low risk. It 
may not require medication therapy.  However, lifestyle modification is encouraged at any level 
in the care of patients as it helps maintain good health.  With more than a low-risk score of 2 or 
more, anticoagulation, therapy for the prevention of stroke, becomes necessary (Deitelzweig, 
Jing, Swindle, & Makenbaeva, 2014). 
Summary 
CHA2DS2-VASc is a useful screening tool for stratifying AF patients to determine the 
need for anticoagulation therapy in other to prevent stroke.  Reviewed literature recommended 
this evidenced-based screening tool for effective stratification of AF patient's risk for stroke, in 
other to provide appropriate interventions.   
Findings included using this tool to reduce stroke risk, comorbid conditions, and resultant 
effects associated with AF.  Findings also included open areas of research regarding the 
CHA2DS2-VASC scoring scheme concerning renal failure and dementia.  Using the CHA2DS2-
VASc tool will help staff adhere to standardized practice guidelines set by the ACC/AHA/HRS 
for the identification of AF patient’s risk factors for stroke.  Using CHA2DS2-VASc tool will 
continue to sustain change from the project in primary care.  Direct advantage and outcome is the 
identification of risk factors that will help providers to decide the intervention to implement in 
other to prevent stroke.  Indirect benefits included stroke prevention, improved quality care, 
improved quality of life, decreased cost of healthcare. 
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Chapter Three:  Theory and Concept Model for Evidence-Based Practice 
The concepts that supported this quality initiative project includes risk factors, risk 
stratification, atrial fibrillation, quality improvement, and collaboration.  Analysis of these 
concepts as they relate to the QI evidenced-based screening tool CHA2DS2-VASc was covered.  
This chapter explored the nurse practitioner's model framework that underpinned the project, as 
well as its application to practice change. The process change and project sustainability at the 
primary care site were evaluated with the Plan-Do-Study-Act (PDSA) evaluation model. 
Concept Analysis  
Risk factor.  A risk factor is a personal characteristic, or toxin exposure to an individual 
that increases the susceptibility of developing a disease, injury, or death.  More specifically, a 
risk factor is a measurement associated with the probability of illness or death, of which the 
patient may not be aware of (Willadsen et al., 2016). Occasionally, risk factors are actual disease 
diagnosis but can also be risk factors for other disease processes (Willadsen et al., 2016).  Atrial 
fibrillation (AF) is an essential determinant of stroke.  For AF patients, stroke risk includes 
conditions like heart failure, prior stroke or transient ischemic accident (TIA), hypertension, and 
advanced age of ≥65.  Other conditions that increase stroke risk include (1) diabetes mellitus 
(DM), (2) vascular diseases, i.e. peripheral artery disease, (3) myocardial infarction, (4) aortic 
plaque, and (5) female gender. These comorbid conditions all predispose patients to AF and 
subsequent ischemic events.  When providers identify risk factors, providers and patients may 
act to prevent disease (Huckel Schneider, Gillespie, & Wilson, 2017).   When providers use the 
CHA2DS2-VASc screening tool to identify AF patient’s risks, the identification provides an 
opportunity for healthcare providers to reduce patient risks, prevent stroke, and improve patient 
outcomes. 
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Risk Stratification.  The concept of risk stratification or classification determines the 
high, moderate, or low levels of probability of an injury or death.  It is a variable determinant of 
increased or decreased levels of risk (Huckel Schneider, Gillespie &Wilson, 2017).  In this 
project, stratification classifies which patient has a low, moderate, or high score.  Stratification 
can offer benefits to patients by helping to determine components of a care management plan and 
prioritization of health care (Huckel Schneider, Gillespie, & Wilson, 2017).   For this reason, 
screening may reduce readmissions, improve patient satisfaction, and increase good patient 
outcomes. (Huckel Schneider, Gillespie & Wilson, 2017).  Patients with AF are predisposed to 
cerebral ischemia and infarct because of thromboembolism. Therefore, stratification of variable 
scores based on heart failure, hypertension, age of ≥ 65, DM, prior stroke or TIA, vascular 
disease, and female gender is useful to detect higher or lower risk of stroke.  Among AF 
population, risk factor identification is crucial to prevent cerebral ischemic disease.  Identifying 
AF patients with a stratified screening tool is the essence of this QI project because it directs 
high-risk patients to thromboembolic stroke prevention by a prescribed intervention.   
Atrial fibrillation.  A supraventricular rapid, irregular heartbeat that emanates from the 
left atrium of the heart as a dysrhythmia, which may cause palpitations, fatigue, and shortness of 
breath (Staerk, Sherer, Ko, Benjamin & Helm, 2017).  Patients with AF have the most common 
disorder of the cardiac rhythm, which causes stasis of blood in the heart and increases the risk of 
arterial thromboembolism and stroke five-fold (Yamashita, 2016).  An understanding of 
Virchow’s Triad (see Appendix D) shows that AF involves abnormalities in blood coagulation, 
vessel dysfunction, and poor blood flow seen in AF patients (Byrnes & Wolberg, 2017).  
Virchow’s Triad, according to Yamashita (2016), involves: 
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Not only abnormalities in blood flow but also blood constituents and the antithrombotic 
function of the vessel wall would play a role based on the assumption that thrombus 
formation in the fibrillating left atrium has many similarities to that in the vein. In the 
fibrillating atrium, the triads correspond to a decrease in blood flow, abnormalities in 
coagulation factors, and atrial endocardial dysfunction. (p. 2377).  
Research suggests that AF contributes to at least 15% of all strokes (Yamashita, 2016).  If 
providers identify AF patients, even when asymptomatic, they can prevent stroke and its 
comorbidities, which will positively impact the lives of their patients. 
Quality improvement. QI is significant to patient care, and reduction of harm as it is the 
basis used to improve the care delivered to patients systematically (White, Butterworth, & Wells, 
2017).  Quality improvement characterizes a process that can be analyzed, measured, controlled, 
and improved (White, Butterworth, & Wells, 2017).  With the US aging population, healthcare 
costs, patient safety, and the changing healthcare needs are areas of concern for healthcare 
providers. For this reason, QI alleviates some of the problems of health care related to the aging 
population.   
QI is significant to patient care due to the harm reduction used to improve the care 
delivered to patients systematically (White, Butterworth, & Wells, 2017).  Quality improvement 
characterizes a process that can be analyzed, measured, controlled, and improved (White, 
Butterworth, & Wells, 2017).  Considering the US aging population, healthcare costs, patient 
safety, and changing healthcare needs have become concerns for healthcare providers. For this 
reason, QI alleviates some of the problems of health care among the aging population.   
It is imperative to know that this quality improvement project is not a research project 
and will not provide treatment to the AF patient.  It is an improvement process in identifying AF 
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patients at more than low-risk scores of a stroke, with the evidenced-based tool, CHA2DS2-
VASc, in the primary care setting.  This QI will also include a recommendation for oral 
anticoagulation therapy for the prevention of stroke.   The first step is the identification of 
patients at risk and recommendations for the intervention to prevent stroke. The next step and 
future QI projects to treat with OAC to prevent ischemic events.  Identifying the AF patient helps 
in shaping the interventions the patients receive, which improves the quality of care they receive 
and improve their lives. 
 Collaboration. Green and Johnson (2015), in their work on professional collaboration in 
research, education, and clinical practice, wrote that collaboration occurs when two or more 
entities work together to produce a desired and shared outcome.  Interprofessional collaboration 
occurs among different disciplines and at different levels (Green & Johnson, 2015) to produce 
cost-effective and comprehensive care (O’Reilly et al., 2017).  In healthcare, the Doctor of 
Nursing Practice (DNP) and other advanced practice registered nurses (APRNs) work together 
with physicians, therapists, pharmacists, social workers, and other clinicians in primary, 
secondary, and tertiary care, to gain professional growth and exchange knowledge.  The different 
disciplines collaborate to research, develop clinical guidelines, and quality improvement for 
better patient care and outcomes.   
 DNPs and APRNs also work with government officials and stakeholders for policy 
changes made into law.  In the primary care setting for this QI project, collaboration is with the 
stakeholders, including one physician, one physician assistant, one nurse practitioner, nurses, 
other healthcare workers, and the office manager.  Other team members are faculty members at 
East Carolina University. 
 




Naming the Model.  The nurse practitioner (NP) care model (Kutzleb et al., 2015) 
provides an underpinning for this QI project.  The NP care model is a patient-centered 
collaborative approach that integrates medicine, nursing, individualized care of patients, and 
therapeutic disease management to achieve a great outcome in patient care initiatives.  These 
initiatives have been successful in acute care, emergency departments, outpatient settings, or in 
the use of evidence-based initiatives that are central to the improvements of risk factors in heart 
failure patients (Kutzleb et al., 2015).  The NP care model helped in monitoring and managing 
care for patients with chronic heart failure (Kutzleb et al., 2015).  The model was designed to 
provide efficient, high-quality care to the heart failure patient population, produce adequate 
patient satisfaction, and save cost in the health care system. It achieved the goal of the Triple 
Aim of population health, quality care experience, and deduction in per capita cost (Institute of 
Health Improvement [IHI], 2017).  Patients with heart failure were identified as high risk for 
early rehospitalization (Kutzleb et al., 2015).  With the NP care model, a QI initiative identified 
risk factors for intervention that decreased rehospitalization (Kutzleb et al., 2015). 
The NP care model targets the risk factors of lifestyle modification, including medication 
noncompliance, diet nonadherence, and lack of self-care disease management (Kutzleb et al., 
2015).  While the measurable objective of improved financial performance was met by reducing 
a 30-day readmission record, other objectives in the area of quality patient outcomes, and patient 
satisfaction were met (Kutzleb et al., 2015).   NP care model was a significant success in a nurse-
led initiative program in the hospital.  The nurse leaders collaborated with other disciplines in a 
Healthy Heart Initiative Program to reduce the readmission rate (Kutzleb et al., 2015).  Before 
the program, the readmission rate for 30 days post-discharge was 26% in the year preceding the 
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initiative.  After the QI initiative, the readmission rate for the 30 days post-discharge reduced to 
8%, which dropped the hospital cost and increased patient satisfaction (Kutzleb et al., 2015).  
Application to practice change.  The NP care model provides a grounding for the QI 
project by identifying patients with AF who are at risk for stroke.  The NP care model was 
chosen because it is one of the first successful nurse practitioner-led models that optimized the 
expertise, education, clinical practice, and experience of NPs in various successful patient care 
initiatives.  Utilizing the NP care model in this QI, it achieves the Healthy People 2020 goal of 
“improving cardiovascular health and quality of life through prevention, detection, and treatment 
of risk factors for heart attack and stroke.” (Office of Disease Prevention and Health Promotion 
[ODPHP], n.d.). 
The plan is early identification of stroke risk factors ([ODPHP], Healthy People 2020), 
which is this QI project’s primary outcome.  Using the NP care model, this QI project achieved 
the goal of the Triple Aim of improving the individual population health through the 
identification of risk factors and prevention of stroke with the recommendation of OAC (see 
Appendix I).  The second goal of the Triple Aim is achieved by reducing the cost of healthcare 
for the patient population and the taxpayers (IHI, 2017).  Prevention of stroke reduces the cost of 
hospitalization and comorbid healthcare-related costs.  In this DNP project, stroke risk factors 
are stratified in other to identify patient’s risks.  Based on the stratified and identified risk scores, 
oral anticoagulation therapy may follow.  Empirical studies and evidence-based practice have 
shown that using CHA2DS2-VASc to determine stroke risk among AF patients is beneficial 
(Ding et al., 2017).  The benefit in identification allowed for interventions channeled to the 
patient.  Other benefit includes quality care that decreases stroke, and cost of healthcare-
associated with thromboembolic events, as mirrored in the NP care model (Kutzleb et al., 2015).    
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Identification and interventions improve patient health, decrease healthcare costs, and 
achieves a Healthy People 2020 goal of preventing and reducing heart attack and stroke 
(ODPHP, n.d.).  In the NP care model, cardiovascular patients at high risk were targeted and 
identified for preventive services and quality care.  This model’s use in this QI identifies patients 









Figure 1:  Application of the NP Care Model to the QI - Using the CHA2DS2-VASC  
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In applying this model to this project, an interdisciplinary effect resulted.  APRNs 
collaborated with physicians, nurses, physician assistants (PAs), and ancillary staff to achieve the  
objectives of this QI (see Figure 1).  In clinical practice, when healthcare professionals work 
collaboratively and APRNs use their leadership and clinical expertise, there is a great success for 
patients, physicians, and the healthcare organization (Thew, 2016). 
Evidenced-Based Process Change Model  
The Plan-Do-Study-Act (PDSA) is an evidence-based practice change model, applied in 
this QI project to guide the change process in the primary care site of the project. The PDSA is 
useful in testing and evaluating change (IHI, 2017).  In this PDSA model, the cycle is a symbolic 
worksheet for testing a change by developing a system to test the change (Plan), implementing 
the test (Do), analyzing and learning from the consequences (Study), and determining what 
changes to be made to the test (Act) (IHI, 2017). The PDSA worksheet used is an ongoing cycle 
that assesses any shift, including quality initiatives and projects.   
Applying the PDSA involves using the tools at the QI project’s site with the stakeholders 
in the primary care clinics.  As a cycle, the project plan is developed, implemented, studied, 
evaluated, and re-evaluated for modifications.  The PDSA will ask and answer questions 
regarding what the QI project is trying to accomplish, the need for change, the persons involved, 
whether the change is an improvement, and if a change occurred. (see Figure 2). 
 PDSA is an efficient worksheet for instituting change in healthcare.  Healthcare changes 
happen rapidly, perhaps more than some providers can keep up with at times.  PDSA provides a 
quick and easy way of testing change, even as research has shown (IHI, 2017). 
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Figure 2.  PDSA Model for CHA2DS-VASc.  (Institute of Health Improvement, 2017) 
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More so, it is instrumental in testing change for quality improvement projects in health care (IHI, 
2017).  For this reason, the PDSA used as an analysis for change in this QI project is helpful. 
  Application to practice change.  PDSA will help document and develop the plan to test 
the change agent.  The tools include the CHA2DS2-VASc screening tool with directions on how 
to use the screening tool. The staff education material consists of a PowerPoint presentation on 
CHA2DS2-VASc and the QI, the data collection tool (see Appendix G).  After the training, the 
providers will have access to the screening tool for implementation purposes.  The providers will 
screen for the identified risk factors by asking questions or through chart review.  The 
CHA2DS2-VASc points range for each patient is 0-9.  Age is only scored one time, which is 
either age 65 to 74 years, or age equal to or ≥75 years.   
According to the 2019 Guidelines of American College of Cardiology, American Heart 
Association, and Heart Rhythm Society (AHA/ACC/HRS):   
Female sex, if the only risk factor, does not confer a CHA2DS2-VASc score of 1. Female 
sex adds to the score only when another risk factor is present. Oral anticoagulants are 
recommended for patients with AF and elevated CHA2DS2-VASc scores — ≥2 in men 
and ≥3 in women. (Link, 2019). 
Plan. All providers will receive training on the use of the screening tool (see Appendix 
C).  A staff education tool (see Appendix E) was designed to educate staff on the CHA2DS2-
VASc screening tool before implementation. The providers received education on the project 
and the use of the risk assessment and stratification form.  A data collection tool was developed 
to collect pertinent data during the chart review and data collection period of the project 
implementation (see Appendix G).  
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Do.  The providers will use the screening tool CHA2DS2-VASc to screen and score 
patients who have a diagnosis of AF and are 65 years and older. The project leader will collect 
and collate data from the screening tool used by the providers to identify patients during the 
implementation.  The PDSA cycle assesses and evaluates for proper identification of AF patients 
with the risk assessment tool.  The number of patients recommended for oral anticoagulation 
(OAC) therapy is a measurable objective.  This number will constitute the moderate and high-
risk levels. 
Study.  Close surveillance, observations, and evaluation of the implementation process 
are carried out every week to ascertain the proper use of the screening tool and process.  Using 
the predesigned tool will help focus on the implementation of the project in other to get the 
desired outcome.  
Act.  An evaluation of the outcome of the application will help to determine the 
appropriate use of the screening tool. Assessment of the results will help to meet any 
modifications that need to be carried out in the implementation and intervention phase of the 
quality improvement project.   
Summary  
Analysis of the concepts of the QI includes risk factors, risk stratification, atrial 
fibrillation, and quality improvement. A risk factor predisposes an individual to develop a 
disease, injury, or death.  Identifying an AF patient’s risk for a cerebral or ischemic event with 
the CHA2DS2-VASc screening tool is necessary to reduce their susceptibility and prevent a 
stroke.   
Atrial fibrillation causes stasis of blood and is a significant risk for stroke.  Stratification 
of other risk factors for AF and stroke is key to using the evidenced-based screening tool 
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CHA2DS2-VASc to score and identify patients at low, moderate, or high risk for a possible 
recommendation of oral anticoagulation therapy or lifestyle modification.  Other risk factors for 
AF include heart failure, prior stroke or TIA, hypertension, the advanced age of 65 and above, 
DM, vascular diseases, myocardial infarction, aortic plaque, and female sex.    
A distinction of no human subject makes this project a QI and not a research project.  
Another concept important to this project is a collaboration between medical and nursing 
professionals, which helps to enhance the project outcome.  This project will be implemented up 
to where the leader and provider make a recommendation for anticoagulation therapy.  
The framework that supports this project is the NP care model developed by nurse 
practitioners and successfully piloted a QI project with the model.  The application of the model 
to this QI project helps produce a positive outcome.   
A PDSA cycle is the evidenced-based practice change model that evaluates the 
implementation and the change process.  The result is that when providers identify AF patients 
with moderate or high risk for stroke using the CHA2DS2-VASc tool, they will reduce the 
incidence of stroke in the patients taking oral anticoagulation therapy.  Indirectly their care 
quality and quality of life are improved.  Furthermore, providers will be able to reduce the cost 
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Chapter Four:  Pre-implementation Plan 
This chapter describes the pre-implementation plan for a QI project on screening AF 
patients for stroke risks. This chapter also explains project management, interprofessional 
collaboration, and risk assessment.  Organizational and IRB project approval processes are 
presented (East Carolina University & Medical Center Institutional Review Board, n.d).  This 
chapter further discusses project cost analysis, data management, outcome, and how results were 
evaluated.  A summary page concluded the chapter. 
Project Purpose 
 The project's purpose was to increase the identification of atrial fibrillation (AF) patient’s 
risk for a thromboembolic event using the CHA2DS2-VASc screening tool at a southeastern NC 
primary care clinic in other to recommend an intervention that will prevent stroke.  The 
CHA2DS2-VASc screening tool will also improve (1) staff adherence to screening AF patients 
and identifying their risk for stroke, (2) stroke prevention and health care quality, and (3) health 
outcomes among the AF patient population.   
Project Management 
Organizational readiness for change.  The project site assessment for organizational 
preparedness for change showed that employees have positive beliefs and perceptions of 
commitment to complete the project (Sharma et al., 2018).   The corporate culture showed staff 
interest in the stroke risk identification method.  The Medical Director, the Physician Assistant 
(PA), and the Nurse Practitioner (NP) at the clinic participated in the QI project to identify 
patients at risk for stroke.  Discussions with the clinic's medical director produced a shared 
consensus about screening needs and project goal achievement.  The nursing staff were eager 
and committed to learning about the project during staff training. Organizational culture, 
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including employee attitudes and beliefs, were positive towards innovation and change, which 
were needed in the culture to promote change (Bayot, & Sharts-Hopko, 2019).  The clinic had no 
standardized screening tool to identify AF patients at risk for stroke.  
Interprofessional collaboration. According to Green & Johnson (2015), 
interprofessional collaboration means different professionals and disciplines working together 
for a purpose like to produce the desired outcome.  In this project, the DNP student implemented 
the project in partnership with the medical director, who championed the project. A physician, 
NP, and PA helped to screen patients during implementation.   Nursing staff coordinated 
appointments between the DNP Student and the providers.  The clinic's office manager liaised 
with the DNP project leader.  Others involved are the faculty of East Carolina University who 
guided the writing of the DNP project as displayed in the hierarchy of interprofessional 
collaboration for the project (see Appendix I). 
Risk management assessment.  A SWOT analysis discussed the strengths, weaknesses, 
opportunities, and threats experienced during project completion.  The SWOT elements were 
affected by internal and external factors that impacted the project (Crowfoot & Prasad, 2017).   
Strengths.  Identifying patients at risk for stroke with the CHA2DS2-VASc tool resulted 
in enhanced project goal of increased provider adherence to using the screening tool to identify 
patients at risk for stroke. Stroke prevention with oral anticoagulation therapy contributed to 
improved quality of care and better patient outcomes.  Interprofessional collaboration is a 
strength because it helped to produce shared project outcomes.  
Weaknesses.  The perceived weaknesses included staff not using the tool to identify 
patients at risk for stroke.  Lack of knowledge about using the screening tool and incorrect 
stratification due to wrong scoring is also a possible weakness (Savoy, 2017).  These weaknesses 
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would be eliminated by staff re-education within the pre-implementation period.   
Opportunities.  These included improved adherence to stroke risk screening. Staff 
assistance in project implementation and completion identified patients at risk for stroke at the 
micro-level in the clinic.  The project was expected to grow to a macro-organizational level as a 
standardized screening among other primary care clinics. The project was expected to evolve 
into a precise treatment intervention.  
Threats. One perceived threat was a lack of sustainability at project completion.  
Sustainability was dependent upon continued use of the screening tool.  Another perceived threat 
to the project was reduced, clinical staff compliance.  Another threat was the patient’s non-
compliance with recommended OAC (see Appendix J). 
Organizational approval process.  Approval to conduct the DNP project was obtained 
from the clinic's medical director during the project's leader's clinical rotation.  Following 
discussions about problems associated with atrial fibrillation, stroke, and using the CHA2DS2-
VASc screening tool, the DNP student requested to conduct the project at the primary care site.  
The medical director granted this request, agreed to be the site champion, signed a contract with 
ECU, and then wrote a letter of support to the project leader (see Appendix K). The stakeholders 
included the champion, a physician assistant, a nurse practitioner, nurses, and ancillary staff. 
 Information technology. The project site's computer program, E-Clinical Works was 
used to review charts.  Microsoft Excel was used to prepare the budget and cost analysis of the 
project.  The DNP student used Microsoft word to type the project and to design the data 
collection instrument.  Microsoft PowerPoint Presentation was used to design the staff 
educational material and poster presentation (see Appendix O).  Electronic health records (EHR), 
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E-Clinical Works helped to review clinic charts.  Demographic data and project-specific 
questions completed by providers helped to analyze data. 
Cost Analysis of Materials Needed for Project 
 Project costs comprised of traveling to the project site, food for staff, and printing costs. 
The total cost budgeted for the project was $500. The total spent was $480, saving a total of $20. 
The DNP graduate saved money from printing at an inexpensive copy center and some copies 
that the project champion authorized in the clinic one time for his file (see Appendix L).    
Plans for Institutional Review Board Approval 
 Approval by both faculty and site champion deemed the project a quality improvement.  
Per ECU DNP requirements, the DNP student completed ECU's IRB approval process. The 
Quality Improvement Tool/Program Evaluation Self-Certification Tool was submitted to the 
DNP faculty lead for prior approval and then submitted through the ECU/IRB website. The 
project was considered a quality improvement and did not require ECU IRB approval (see 
Appendix M). 
Plan for Project Evaluation 
Demographics. Demographic details were collected and analyzed statistically.  
Demographics included gender and age.  Gender was reported as the number of male and female 
participants.  Age of subjects in the data collection sheet was reported as ranges of 65 to 88 
years, and 89 years and over, due to HIPPA stipulations. Stratification levels and 
recommendations for OAC were reported as ranges (see Appendix N). Implementation and data 
collected were presented in a narrative statement, graph, and pie chart (see Figure 3).   
Outcome measurement.  Outcome measures are high-level contributions in health care 
organizations (Jones, 2016). Outcomes included direct identification of patient's risks.  Another 
IDENTIFYING STROKE RISK USING THE CHA2DS2-VASc 42 
 
 
outcome is the recommendation for OAC to prevent stroke, staff adherence to the use of the 
screening and stratification tool for the patients.  Indirect outcomes included stroke prevention, 
increased high-quality care to patients, and improved quality life for patients.    
Was the CHA2DS2-VASC screening tool used to screen patient?  This outcome 
measured evidenced-based tool use at the clinic site.  This measure helped the staff adhere to 
using the tool (Jones, 2016).  This process measure ensured that providers completed the 
screening.  Continued screening tool use increased provider adherence to patient screening and 
the sustaining of the project.   
Did staff stratify patients for identification? This outcome measure identified and 
stratified patient's risk to receive the recommended intervention to prevent a stroke.  This 
measure was a process site outcome. 
Was the recommendation made for OAC to prevent stroke?  This patient outcome 
identified patient-risk and recommended treatment for stroke prevention.  This measurable 
outcome produced the number of patients identified at risk for stroke.  The patients received a 
recommendation for OAC when identified with two or more scores.  With a recommendation, 
patients would begin OAC to prevent stroke.  If a stroke is prevented, the patient experiences 
better quality care.  Better quality care increases trust and a therapeutic relationship with the 
provider.  Such a patient-provider relationship is known to improve the health and quality of life 
indirectly.  The use of the CHA2DS2-VASc screening tool in patient stratification represented a 
process measure.  Stratification was one of the screening tool's objectives because it classified 
patients' risk level to recommend them for intervention.  The intervention was for OAC or 
lifestyle modification.   
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Evaluation tool. A PDSA cycle evaluated whether the QI project was effective in 
meeting its goals and objectives (IHI, 2017).  The goals included to screen, identify stroke risk 
factors, stratify the risks as low, moderate, or high risk, and to make an OAC recommendation if 
the patient had more than low risk.  The project leader assessed the results from week one of 
implementation to ascertain proper use of the screening and stratification tool.  After the first two 
weekly evaluations, a bi-weekly surveillance chart review was conducted, and information was 
entered into data collection worksheet.  The PDSA Model was obtained from the Institute of 
Health Improvement Website.   
Data analysis. A biweekly chart review of the EHR was performed, and the completed 
CHA2DS2-VASc data collection sheet was updated.  Data were extracted from the CHAD-
VASc EHR patient encounter, collected, collated, and tabulated.  The number of AF patients 65 
years and older screened were compared with the number of patients with moderate and high-
risk scores that met with OAC recommendation.  This DNP QI project did not provide OAC 
treatment.  OAC treatment was the next level research project that involved IRB clearance due to 
human subjects.   Instead, this QI project initiated and identified patients at risk for stroke 
through increased use of the screening tool.  There are no organizational, local, state, or national 
benchmarks in existence.  However, data analysis indicated that an estimate of over 50 % of the 
primary care AF patient population was screened, identified, and recommended for OAC 
treatment. Those patients had a reduced risk of suffering a stroke based on the project's OAC 
recommendation and AHA guideline. 
Data management. Storage of data included an ECU pirate account that was confidential 
and secured with user ID and password. The project was stored for educational needs in the ECU 
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secured scholarship website. No PHI was included in the survey, and all data collection tools and 
collected data were shredded after data extraction. 
Summary 
This QI project increased patient screening and identification of stroke risk.  Pre-
implementation required organizational readiness for change assessment, which revealed 
employee perception of eagerness and commitment to the change.  Employee belief included a 
high-quality care corporate culture.  Absence of an onsite, existing identification tool supported 
need to continue the QI.  In conducting the QI project, an interprofessional collaboration 
developed among the ECU CON faculty, DNP student, physician, NP, PA, office manager, and 
other staff.  A SWOT analysis discussed strengths, weaknesses, opportunities, and threats that 
might affect the project. Organizational approval granted by the primary care clinic's medical 
director helped to commence the project.  The ECU IRB categorized the project as a QI process, 
which did not involve human subjects and required no IRB approval.  E-Clinical Works, the 
project site's EHR, was used to review data and compare it with the data collected with the data 
collection tool for evaluation.  While Microsoft Word, PowerPoint, and Excel were used to 
create, organize, and manage data, project cost analysis identified the resources used.  Project 
evaluation outlined demographic information collected in the DNP student’s data collection tool.  
Three specific patient outcome measures identified were the use of the screening tool to identify 
the patient’s risks, stratification based on low, moderate, and high risks, and OAC 
recommendation for stroke prevention.  The PDSA tool helped to evaluate the outcomes.  Data 
analysis indicated that 50 of the AF patient population were screened and identified.  Over 80% 
of the AF patients received a recommendation for OAC thereby preventing stroke for them.  
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Chapter Five:  Implementation Process 
Implementing an intervention with evidenced-based tools like CHA2DS2-VASc is an 
essential step toward the completion of a QI project.  It is the tipping point for the success of the 
project.  Collaboration from all the participants helped to identify stroke risk.  This chapter 
describes the project site and details the recruitment process of the participants.  The chapter also 
describes the project participants.  This chapter discussed the ease, and the barriers experienced 
while recruiting for participants and implementing the project.  A narrative of the staff 
perception and all processes resulted.  The chapter ended with summarized conclusions. 
Setting 
 The project site was an outpatient primary care clinic in southeastern NC with about 
12,000 active patients, of which 90% are adults.  The project site is an independently owned care 
practice set up to care for patients on a for-profit basis.  This practice, established in 1987, is 
situated in a well-populated area.  The site had affiliations with an Accountable Care 
Organization (ACO).  An ACO is an independently owned but coordinated health-care providers, 
hospitals, who voluntarily give high-quality, coordinated health services to Medicare patients 
(United States Centers for Medicaid and Medicare Services (CMS, 2019).  The ACO aimed at 
coordinated care that ensured high-quality, right time care for patients, thereby reducing cost, 
eliminating duplication of services, and medical errors (CMS, 2019).   
 The outpatient clinical site is affiliated with a large university and committed to 
providing higher educational standards through preceptorship and project site support assistance.  
The clinic bills Medicaid and Medicare or private insurance for service.  There was no stake 
identified except for the voluntary enhancement of graduate education and improvement in 
clinical outcomes. 




The stakeholders were the participants: one Physician, one Physician Assistant (PA), and 
one Nurse Practitioner (NP).  Others were nurses, healthcare workers, and the office manager.  
The Medical Director was a licensed physician who provided health care to patients in the clinic.  
The NP and PA were licensed providers that provided health care to the clinic population.  The 
clinic nurses received training on the screening tool to understand the QI project.  The three 
licensed providers helped implement the project; however, nurses and ancillary staff did not 
participate in the implementation of the project.  The office manager assisted in providing the 
project leader access to clinic statistical data and a description of the clinic. Clinical personnel 
excluded from the implementation of the project included (a) interns, (b) students on clinical 
rotation.   
Recruitment 
 In discussion with the medical director in the Fall of 2018 on the CHADS-VASC topic, 
the project idea emerged, and the DNP student recruited the medical director as site champion.   
In 2019, the DNP student discussed with the site champion the need for the NP and PA regarding 
being part of the implementation.  The medical director communicated the willingness of the NP 
and the PA to participate in the implementation of the project.  All participants formed a 
convenience sample as they were employees of the clinic.  The participants thought the project 
was feasible and will bridge the health care gap, including the need to improve the 
standardization of identifying AF patient's risk for stroke. The participants believed in the 
efficient quality care to the patients in a cost-effective way. The participants were interested and 
willing to implement the project.  There were no barriers to the recruitment process of the 
participants. 




Pre-implementation Phase.  The pre-implementation phase began by identifying the 
problem of interest and the high cost to the patient, clinic, healthcare, and taxpayers. The project 
leader discussed with the medical director of the project site on the need to improve care for AF 
patients at risk for stroke in the clinic.  Further discussion on the topic occurred with ECU-CON 
faculty.  A SWOT analysis detailed the strength, weaknesses, opportunities, and threats of the 
project.  A PDSA set up for the evaluation of the project, and the outcome availed for the project.  
The planning phase of the PDSA aimed at providing the data collection and education tools, 
setting up meetings, and staff education on the identification process.  This process included the 
use of the risk stratification tool CHA2DS2-VASc to identify and stratify AF patient’s risks into 
low, moderate, and high levels.  Planning also included recommending OAC for a patient with 
moderate or high-risk scores.  The project presentation to the College of Nursing and IRB for 
approval proved satisfactory.  The leader obtained ECU-CON institutional permission in summer 
2019, and the IRB considered the project a QI, and with no approval required.  Staff at the 
project site received a pre-implementation education with a PowerPoint presentation on the 
project.   
Implementation Phase.  EHR data revealed that the clinic has about 12,444 active 
patients registered in the clinic.  Out of that 12,444 patients, 3279 patients or 26.3% of the 
population were adults 65 years and older, and about 130 were AF patients.  During 
implementation, the participants screened mostly patients with a diagnosis of AF 65 years of age 
and older.  Though the majority of the patients were 65 years of age and older, the project 
specifically addressed the AF population as a project requirement.   
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The PDSA cycle used to monitor and evaluate the implementation and change process 
reflected this the age limit of the population. The patients with a diagnosis of AF were screened 
with the CHA2DS2-VASc and stratified to identify their risk levels (see Appendix D).   
Providers specifically asked questions about the risk factors and assigned scores of 0 to a 
“no” and 1 to a “yes”. An exception to that rule is the age of 75 years and older, and a prior 
ischemic event or a transient ischemic attack (TIA) assigned a rating of 2 each.  The participants 
added the scores and stratified a patient at a level of either low, moderate, or high risk for stroke, 
which indicated the need for anticoagulation therapy or not (Deitelzweig, Jing, Swindle, & 
Makenbaeva, 2014).   
According to the CHA2DS2-VASc screening tool, scoring is given to the risk factor of 
age though there are two age limits in the tool (a) age ≥ 75 and age 65 – 74 (see Appendix D).  
The highest possible rating scored by a patient was 9.  A score of 9 placed a patient at a 15.2% 
annual risk of having a stroke. The numbers stratified in ranges include (a) no risk scored a 0, (b) 
low-risk score a 0-1, (c) moderate risk assigned a 2-4 score, and (d) high risk assigned a score of 
5- 9.   Moderate and high-risk levels required intervention with OAC according to the 
AHA/ACC/HRS Clinical Practice Guidelines (January et al., 2019).  AHA/ACC/HRS 
recommends that any score of two or higher requires OAC to prevent stroke or 
thromboembolism because, the higher the score, the greater the risk of stroke for the patient 
(Deitelzweig et al., 2014).   
   The study section in the PDSA model assessed the implementation outcomes against 
the implementation criteria.  The evaluation started in the first week of implementation.  Weekly 
surveillance ascertained proper use of the tool and plan in other to provide re-education or make 
corrections if indicated. The evaluations checked whether the implementation answered the 
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project questions and whether the project followed the established plans. Evaluations also 
verified the CHA2DS2-VASc screening tool use and if the project accomplished the targeted 
goal of at least screening 50 patients.  Answering the PDSA questions directed the 
implementation and intervention to the desired outcome.  As a cyclical model, PDSA guided the 
continuous evaluation of the implementation and outcome at each stage of the implementation.  
The project leader collected data from EHR chart reviews weekly with the data collection sheet 
and tabulated the data.   
          Post Implementation Phase.  The DNP student continued outcome measure evaluation 
with EHR chart reviews using the Data Collection Tool.  The evaluation of measurable outcomes 
included the number of patients screened with the CHA2DS2-VASc tool and the number of 
patients in each level of risk. Interval worksheets, excel chart run, and graph provided visual 
change process.  This outcome indicated that the participants used the CHA2DS2-VASc 
instrument to screen patients.  The outcome also indicated that participants adhered and complied 
with the AHA/ACC/HRS Clinical Practice Guidelines.  Post-implementation data showed that 
the participants screened a total of 50 patients.  Stratified levels of the patient’s risk included 
low, moderate, and high.  All moderate and high-level scores received a recommendation for 
OAC.    
 The screening process was done electronically and has become a part of the patient 
clinical encounter record, which will help to sustain the project.  The project has directly 
increased identification and indirectly improved the quality of care for patients through 
therapeutic intervention to prevent stroke.  As a result, patient care improved indirectly.  All 
patients received secondary prevention of stroke and indirect enhancement of their quality of life.  
The implementation was considered a success, with 50 target patients screened and identified 
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with the CHA2DS2-VASc tool.  Out of the 50 patients, 82% of the total patient population 
screened met eligibility for OAC recommendation. 
Plan Variation  
 Previously in the summer of 2019, a variation was made in the implementation process 
to screen all patients with a diagnosis of AF in the clinic.  However, during implementation, with 
faculty consultation and guidance, A change was made to screen AF patients who are 65 years 
and older only.  This change in the implementation process narrowed the focus.  The narrowed 
focus made data gathering easier. With more faculty consultation, another plan variation in data 
collection occurred.  The initial plan was to collect data with the data collection tool biweekly.  
However, after consultation with faculty, data collection was changed to weekly from the 
beginning to the end of the 60day implementation period.    
 Another plan variation was the change from manual to electronic screening.  Initially, 
the providers used the paper CHA2DS2-VASc screening tool for screening.  During a PDSA 
cycle process, the CHA2DS2-VASc tool was programmed into the patient EHR encounter for 
ease and accessibility of screening.  This electronic screening helped to make screening and 
identification more accessible.  Being part of the electronic health record encounter helped in the 
sustainability of the project since the tool became a permanent part of the patient’s electronic 
record encounter.  As part of the electronic record encounter ensured being screened by the 
provider during an AF patient encounter.   
Summary 
The QI project conducted in a privately-owned outpatient clinic that saw mostly adult 
patients.  Participants recruited in the summer of 2019 included three providers that screened AF 
patients with the CHA2DS2-VASc screening tool.  Implementation began in the fall of 2019. 
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Data review and collection were done weekly with a data collection sheet by logging into the 
electronic system of the project site.   
Fifty patients were screened and stratified for identification into the low, moderate, and 
high-risk level score.  Some variations occurred during the implementation period, including data 
collection from a biweekly to a weekly phase.  Another change was that all patients with a 
diagnosis of AF and 65 years old were screened and stratified instead of patients that were 65 
years and older as initially planned. This change streamlined the project and targeted the project 
to the AF population.   
The project is a success so far in that this screening became a part of the patient 
electronic screening process in each patient encounter at the project site. Being part of the patient 
encounter assured the sustainability of the project.  It also confirmed provider adherence and 
compliance in using the AHA/ACC/HRS Clinical Practice Guidelines for AF patients.   
Another PDSA process change was in streamlining the number of patients screened in 
one week because after the electronic screening commenced, it resulted in a significant in the 
screening, stratification, and identification.  There was also an increased number of chart reviews 
due to ease of accessibility of chart reviews electronically.  
This completed project was successful as it directly identified and stratified patients and 
indirectly prevented patients from ischemic attacks based on OAC recommendations and 
lifestyle modification.   
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Chapter Six:  Evaluation of the Practice Change Initiative 
This chapter discusses and evaluates the outcome of the changes the QI project brought to 
the southeastern NC primary care clinic.  The participants of the project are described based on 
their demographic data.  A discussion on the short, intermediate, and long-term goals of the 
project ensued.  This chapter discusses the findings from the QI project.  A summary page 
concludes the chapter.    
Participant Demographics 
           Using a participant data collection question tool (see Appendix N), demographic 
information and project-specific questions were obtained from the participants and analyzed (see 
Table 1).  From the data collected, there were three participants in the clinic, including a male 
physician, a female physician assistant (PA), and a female nurse practitioner (NP).  The 
physician who was the site champion for the project is the medical director of this primary care 
clinic. He is a general practitioner with over 26 years of medical experience.  
 With his wealth of experience, the physician is committed to promoting the advancement 
of medical and health practice through education, precepting, volunteering, QI projects, and 
health fairs.  The PA has over 21 years of work experience providing care to all populations in 
the clinic site.  The PA screened AF patients during the implementation stage of the project.  The 
NP is an experienced family nurse practitioner with over 15 years of care provision in this 
practice site.  She also screened AF patients during the implementation stage of the project.  The 
NP programmed the CHA2DS2-VASc screening tool into the E-Clinicals patient encounters in 
the electronic health records.  The NP helped to provide statistical data regarding the AF patients 
for screening and identification.   
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          The participants provided demographic data.  Participants answered three demographic 
questions and two project-specific questions. The participants were supportive of using the 
CHA2DS2-VASc stratification tool to screen AF patients and to identify patients at risk for 
stroke.  Participants all believed that the project brought changes to the clinic.  The participants 
also communicated their belief that the project will cause some extra work for the providers but 
would be worthwhile if it will improve patient outcomes.  The participants reported that the 
CHA2DS2-VASc screening tool screened stratified and identified AF patient’s risk for stroke. 
The providers also reported their willingness to continue using the risk assessment tool.   
 
Table 1. 
Demographic Data and Project-specific Table 
Question MD PA NP 
 
    
Are you an employee of the site? Yes Yes Yes 
What is your gender?  
 
Male  Female Female 
Length of work at the site? 26years+ 21years+ 15Years+ 
Does the CHA2DS2-VASc screening tool identify risk for 
stroke? 
 
Yes Yes Yes 






    
 
Note:  Demographic data and project-specific questions collected from a survey given to 
participants at the project site.  
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Intended Outcome(s)  
Goals are the intended representation of desired ends (Höchli, Brügger, & Messner, 
2018).  Identified project outcomes are classified as short-term, intermediate, and long-term 
goals, as discussed below. However, goals may not be clear cut and can overlap in time and 
achievement.   
 Short term goal.  These goals were the immediate intended objectives or outcomes 
realized from the QI project within one week, one month, or less than one year.  In this project, 
the short-term goals resulted in immediate changes at the DNP project site.  One short term goal 
was the direct utilization of the risk assessment tool in screening AF patients for stroke risk.  A 
short-term outcome goal realized from the QI project was the increased identification of patients 
with moderate and high risk for stroke after applying the screening tool.  Another short-term goal 
achieved was increased adherence to the use of the CHA2DS2-VASc screening tool by the 
providers in the clinic.   The QI project led to the inclusion of screening with the CHA2DS2-
VASc tool as part of the patient’s EHR encounter.  Recommendation for patients in the moderate 
and high-risk levels for OAC is an immediate outcome goal of this project, considering that 82% 
of the AF patients screened identified in the moderate and high-risk levels.   
Intermediate goal.   Prevention of stroke was a secondary goal achieved in the QI 
project. When patients received recommendations for oral anticoagulation therapy, the incidence 
from having a thromboembolic event is reduced. 
Long-term goal.  These included the goals that will materialize in the future and stay 
sustained (Bradley & François, 2017).  Long-term goals can be direct and indirect outcomes of 
the project.  Prevention of stroke and its subsequent comorbidity fall into the long-term outcome 
goals of this project.  When AF patients are screened and identified at the level of moderate and 
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high risk for stroke, recommendations for treatment with OAC reduces the risk of a stroke.  
When a stroke is prevented, the quality of care and quality of life of AF patients is improved.  
The reduced financial burden for the patients and taxpayers is a long-term change from the 
project, considering that stroke costs the US about six billion dollars annually and approximately 
450,000 AF hospitalizations each year (Cutugno, 2015).  In this project, 82% of screened 
patients identified in the moderate and high-risk levels of stroke risk. These patients met 
eligibility for OAC or received a recommendation for OAC.  Considering that it costs about 
$14,000 for one hospital stroke admission, the project saved about $574,000 for the patients in 
the project site and the taxpayers (see Appendix O).  Another intended long-term goal is lifestyle 
modification that prevents stroke through the education of the patients.   
Findings.  
The implementation of the QI was completed for the patients 65 years and older with a 
history of AF.  Fifty patients were screened and stratified to either low (0-1), moderate (2-4), or 
high- risk (5-9) level of stroke.  Nine patients ranked low (18%), thirty-five patients scored 
moderate (70%), and six patients classified as a high-risk level (12%). Eighty-two percent of the 
screened patients were in the moderate and high-risk range.  However, the highest number of 
patients stratified for risk factors remains at a moderate level (see Figure 3).   
Screening with CHA2DS2-VASc for identification of risk factors in AF patients became 
a part of the electronic health record encounter.  Being a part of EHR ensured continued risk 
identification and stratification.  Electronic screening also ensured the sustainability of the 
project.  Screening and identifying AF patient’s risk levels increased providers' adherence to the 
use of clinical practice guidelines for AF patients.  Screening, stratifying and identifying risk  
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factors allowed for a recommendation for OAC for the moderate and high-risk levels to prevent 
an ischemic event.  When a stroke is prevented, the quality of care and quality of life of the 
patient is improved based on the identification of risk factors.  With the recommendation for 
OAC, the providers reserve the clinical judgment not to recommend OAC, where there is a 
contraindication like increased bleeding time.  The QI project potentially reduced the financial 
burden for the patient and taxpayer with each stroke admission prevented. The potential stroke 
hospitalization cost becomes very significant with the number of patients in this project who 












  Figure 3.  Screened patients and the stratified levels of risks. 
Summary 
This chapter evaluated the practice change effect of QI using the evidenced-based risk 







Stratification of Identified Risks
Low Risk 0-1 Moderate Risk 2-4 High Risk 5-9
N=50, 82% screened met eligibility for  OAC
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Three providers screened AF patients in a primary care clinic. The participants identified the 
patient’s risks into low, moderate, or high risk through screening and stratification.  
Demographic and project-specific questions answered by the participants assisted in the 
outcomes of the project.  A total of 50 patients were screened and identified for risk factors in the 
QI project, which occurred over eight weeks. Eighty-two percent of screened patients with 
identified risks received a recommendation for oral anticoagulation therapy.  As a result of their 
intermediate or high-risk levels of stratification, the patient received advice for OAC.     
The short-term goals ensured the usage of the CHA2DS-VASc tool to identify AF 
patients at risk for stroke.  The project increased provider adherence to the clinical guidelines set 
for AF patients.  This increased identification also assisted and ensured the sustainability of the 
project.  The intermediate outcome goals, directly and indirectly, impacted the QI site.  This 
impact resulted from the financial burden associated with AF and stroke that potentially is 
decreased with identification, treatment, and prevention of thromboembolic events.  The majority 
of patients screened were eligible for oral anticoagulation therapy based on their elevated risk 
score. Based on these findings, the QI project was considered a viable and sustainable.  
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Chapter Seven:  Implication for Nursing Practice 
The Doctor of Nursing Practice Essentials provides the foundational competencies 
needed for the practice of advanced nursing (American Association of Colleges of Nursing, 
2006).  It outlined implications for the practice of advanced nursing. These Essentials and 
competencies equipped the APRN for clinical work in the highly advanced technological 
healthcare system of present times. For this reason, this chapter explored the application of these 
Essentials, its implication to nursing practice, and how it related to this quality improvement (QI) 
project. 
Practice Implications 
Essential 1:  Scientific underpinning for practice.  The scientific foundation provided 
the empirical bases for advanced nursing practice.  This scientific backing originated from 
different fields of study, including philosophy, medicine, psychology, ethics, biology, and 
nursing.  This scientific support enhanced the job of the APRN in that it prepared the DNP 
graduate to work safely in the clinical setting.  The scientific foundations govern the 
advancement of clinical practice and provide backing for QI work in clinical settings.  The 
improvement work in clinical settings helped to promote quality care and wellbeing of patients.  
In particular, the evidenced-based tool CHA2DS2-VASC from the AHA/ACC/HRS guidelines 
(January et al., 2019) for clinical practice was used in a QI project to screen, stratify and identify 
stroke risk for AF patients who are ≥ 65years.  The identification helped to provide appropriate 
therapeutic intervention to the patients.   The nurse practitioner care model that provided the 
scientific backing for this project was developed in the field of advanced nursing and used to 
reduce re-hospitalization with cardiovascular patients.  Research work provided support for 
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advanced practice nursing because when empirical knowledge and evidence are translated into 
clinical practice and decisions, care delivery is known to improve (Curtis, Fry, Shaban, & 
Considine, 2017).  In applying scientific backing, the AF patients in this project were screened 
for risk factors and stratified for the identification of increased stroke risk.  These identified 
patients received therapeutic interventions based on their level of risk.  Adherence to this 
screening process in the project site sustained the project and produced excellent outcomes in 
stroke prevention. This project paved the way for future projects that will delve into 
pharmacological interventions to prevent stroke. Recommendations included to carry on the 
project to the next level that will involve pharmacological therapy to prevent stroke. 
Essential II:  Organization and systems leadership for quality improvement and 
systems thinking.   APRNs are ready to lead in the organizational and systemic levels of private 
and government establishments.  This DNP Essential provided adequate tools and preparation 
for the APRN to assess risks, identify problems, and make sustainable quality improvements. 
Through the leadership efforts of APRNs, quality improvements are made based on identified 
needs in the organizational and systemic infrastructures to reduce costs of healthcare to 
organizations and taxpayers.  Through screening and identification of risk factors, AF patients 
received assistance with appropriate therapeutic intervention.  Through leadership decisions, 
APRNs provided cost-effective care, which translated to lower cost for the patients, clinics, 
hospitals, taxpayers, and governmental systems.  Lamb, Martin-Mesiner, Bryant‐Lukosius, and 
Latimer (2018) discussed two leadership areas that APRNs use to improve care delivery and 
environment for healthcare staff, patients, and their families.  These two domains included 
patient-focused and, organization leadership and system‐focused leadership.   These two fields 
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are capabilities that advanced practice nurses use to contribute towards improving the care 
environment for patients and healthcare staff.  
The health care delivery system for this project was an outpatient primary care setting.  
The patients were of diverse backgrounds with ailments and comorbid conditions, such as 
diabetes, congestive heart failure, hypertension, and renal insufficiency.  The staff and 
participants included a physician, a physician assistant, a nurse practitioner, and ancillary staff of 
different educational backgrounds.  The DNP student coordinated meetings and led the project 
implementation, which included preparation of screening materials, designing data collection 
tools, training the participants, leading the project, and in consultation with faculty, developed 
modalities for data collection, and change process.  Several healthcare organizations are willing 
to support APRN led projects that will improve the quality of care for patients. In this project, all 
patients 65 years and older with AF were screened in the clinic and stratified to identify stroke 
risks.  The ECU IRB system reviewed the project and considered it a QI not involving human 
subjects.  The recommendation is to sustain this screening and identification of AF patients and 
their risk levels so that the patients receive an evidence-based intervention.  The proposal 
included the utilization of oral anticoagulation therapy to prevent stroke in patients stratified at 
intermediate risk and above.  Recommendations are for APRNs to lead quality improvement 
projects since health care delivery systems are willing to help sponsor and provide the setting for 
these.  This project conducted at a micro-level can expand into a macro level of care where other 
primary care settings, including private organizations and government establishments, will 
benefit from it.  
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  Essential III: Clinical Scholarship and analytical methods for EBP.  Unlike practices 
that rely on tradition, intuition, and unproven methods, evidence-based practice is a proven 
problem-solving approach based on scientific evidence (Reid, Briggs, Carlisle, Scott, & Lewis, 
2017).  In nursing, EBP helps to guide nursing decision-making and provide a systematic way of 
solving problems in healthcare settings.  EBP provides clinical practice that uses the best 
evidence from research, patient values, preferences, and provider’s knowledge in the care of 
patients (Reid, Briggs, Carlisle, Scott, & Lewis, 2017).  The APRN understands how to find 
scholarly materials and proven scientific work and to use work as EBP into the process of quality 
improvement.   CHA2DS2-VASC is the evidenced-based tool used in this QI.  The application 
of CHA2DS2-VASC to this QI was necessary to the project’s goal because in using this EBP 
tool, a patient could be identified, stratified for risk factors, and given appropriate intervention.  
The literature review in this project was another empirical process that allowed the APRN to 
search through scholarly work, to locate bodies of knowledge that supported the QI 
(Shellenbarger, Hunker, & Gazza, 2015).  A PRISMA diagram organized and presented the 
literature review.  A literature matrix helped to define the levels of evidence (see Appendix A).  
 The project met the goals of the Institute of Health Initiative Triple Aim, which focused 
on the improvement of population health using the evidenced-based screening tool like the 
CHA2DS2-VASC.  The second goal of the Triple Aim centered on patient care; the project 
accomplished through the application of this QI to AF patients.  The third goal of the Triple Aim 
met was the reduction of systemic health care costs.  In this project, the identification and 
stratification of stroke risk levels improved clinical staff adherence to the use of the evidenced-
based tool, CHA2DS2-VASC.  Stratification and identification of AF patients' stroke risks in this 
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micro clinical setting prevented stroke and saved the cost of care.  Stroke risk identification with 
the recommendation of therapeutic intervention like OAC prevented stroke in AF patients 
reduced healthcare costs associated with stroke and AF.  The QI project became part of the EHR 
encounter, which increased the ease of screening and identification with the evidenced-based risk 
assessment tool CHA2DS2-VASc. This ease in implementation increased provider adherence to 
clinical practice guidelines for AF patients.  The project becoming a part of the EHR encounter 
assured sustainability of the project. 
A PDSA cycle that reflected the implementation process helped to accommodate changes 
that occurred throughout the implementation phase of the project. The recommendation was for 
the use of the project to be continued as that will enhance the continued quality care of the 
patients in the clinic and save costs.  A recommendation was for the project to be duplicated in 
other primary care settings that do not have a standardized method of identifying AF patient’s 
risk to get the same result.  Another recommendation was to research the best pharmacological 
interventions to prevent stroke.     
Essential IV:  Information systems/technology and patient care technology for the 
improvement and transformation of healthcare.  The efficient use of the information system 
is vital to clinical practice. Information technology (IT), including Microsoft Excel, was used to 
write the budget, write time log, literature matrix, chart run, to enter, and tabulate data for 
display.  Microsoft Word helped to design and write the project.  The data collection tool and the 
project interval documentations were designed and written in Microsoft Word.  Microsoft 
PowerPoint was used to design and create an education tool.  Electronic screening and chart 
review completed in the EHR E-Clinical program assisted data extraction.  Though no protected 
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health information was used, the APRN must protect any data extracted in the course of chart 
reviews.  The QI project was screened by the IRB to make sure that no violation of identifying 
information occurred. A user ID and password allowed access to the project site EHR for chart 
reviews conducted at the project site.  The chart reviews allowed for the analysis of data under 
CHA2DS2-VASc screening and stratification score.  The data collection tool help to record data 
collected for review, including identification of risk, diagnosis of AF, scoring details, and levels 
of stratification.  The data collection tool displayed the collected data.  The recommendation 
included continued use of the QI in the EHR. 
Essential V: Healthcare Policy for Advocacy in healthcare.  The DNP graduate must 
understand the process of healthcare policy development, which can be through empirical 
evidence, clinical expertise guidance, and quality improvements made to become health policies 
and law.  The different counties and congressional areas in NC rely on healthcare policies that 
meet the need of their population (CDC, 2016).   Healthcare policies and plans supported by the 
APRN can meet the health care needs of clients endorsing the Affordable Care Act, and other 
government programs. The APRN advocated for such policy changes through congressional 
efforts and collaborations, in other to help patients gain access to healthcare programs.  The DNP 
graduate advocated for change in policies to meet the needs of the population served for those 
patients who experience healthcare disparity.  The DNP graduate developed and implemented QI 
projects that effected change and improved care through the identification of AF patient's risk in 
other to prevent stroke for population centered care.  This change was developed and 
implemented by the DNP graduate using an evidence-based (EBP) screening and stratification 
tool to identify those at medium to high risk of stroke. Identification and stratification of the risks 
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helped the DNP graduate to intervene with appropriate therapy.  This EBP tool used in this QI 
affected a change in the policy of the project site by making the QI permanent in the site EHR 
for continued use.  Policy integration in healthcare with sustained QIs produced low-cost quality 
care, increased access to care for those in disparity, and those with sensitive cultural needs.  
Legislative and health advocacy for health policies increased care access for the patient. 
Essential VI:  Interprofessional collaboration for improving patient and population 
health outcomes.  The definition of this Essential dealt with interprofessional connections and 
interactions in a technologically sophisticated healthcare system.  These connections provided 
the safe, timely, and effective patient-centered care required to meet the efficient treatment and 
care of the patient (AACN, 2006).  These interconnections occurred amongst different 
professions and nursing professionals at different levels.  In the QI project, the interprofessional 
relationship was evident between the project champion, who is a physician, and the DNP student, 
a nurse practitioner, and physician assistant, nurses, and ancillary staff. 
Further collaboration between ECU, CON faculty, and primary care physicians opened 
more avenues for growth in education and quality care for the patient.  This collaboration 
resulted in the screening, stratifying, and identifying AF patients to provide the patients with an 
appropriate intervention that prevented them from having a stroke and ultimately saved their 
lives and healthcare costs. Together, the efforts of interprofessional staff working together for a 
unity of purpose resulted in cost-effective, comprehensive quality care to patients (O’Reilly et 
al., 2017).  Recommendations are for continued collaboration that can be expanded to get more 
substantial results like cost-effective care and quality care outcome for patients. 
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Essential VII:   Clinical prevention and population health for improving the nation's 
health.  Following the nation's goals on Healthy People 2020 in preventing and reducing heart 
attack and stroke (ODPHP, n.d.).  This QI identified risk factors that were preventable for stroke 
and cardiovascular symptoms through lifestyle modification and therapeutic interventions.  
Further, the goals of the Triple Aim helped to target and improve the health of the individual and 
population.  This project employed the use of Healthy People 2020 and the goals of the Triple 
Aim through the identification of preventable risk factors for stroke.  In identifying these risk 
factors for appropriate intervention, stratification become important.   In this project, the 
strategies included the use of an evidence-based screening tool to screen and identify AF 
patient’s risks for hypertension, advanced age, diabetes, prior stroke, vascular disease age, sex 
category in patients with AF ≥ 65years.  The recommendation is to use this quality improvement 
to target population health for AF.  and stroke patients for identification and prevention purposes.  
 During this period of COVID-19, APRNs and DNP graduates became frontline workers 
in clinical prevention and population health improvement.  In the effort to improve the nation’s 
health, this pandemic became a time for the autonomy of practice for DNP graduates trained to 
take on that challenge in some states like New York.   
Essential VIII:  Advanced Nursing Practice.  The DNP graduate prepared to take on 
new leadership roles in the private and systemic levels of government. The DNP graduate trained 
and prepared in clinical expertise where utmost judgment and critical thinking are applied.  The 
DNP student mastered the conduction of empirical work that changes the healthcare systems 
through clinical guidelines, DNP essentials, QI, research, policies, and law.   The APRN 
graduate developed this project and collaborated with other professionals to improve the care of 
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AF patients through increased identification of risk factors.  The increased identification allowed 
for a recommendation of therapeutic intervention that prevented stroke  
Summary 
The DNP student established competence in clinical expertise through the DNP 
Essentials.  This QI project and its outcomes gave experience to the DNP prepared student to be 
ready to take on leading roles in a healthcare system that is ever dynamic.  The DNP graduate, 
through the competencies and Essentials, covered tenets of health care policies that meet the 
needs of the population and the goals and guidelines set by national organizations.  The Healthy 
People 2020 and the IHI Triple Aim goals addressed the need for the national healthcare systems 
in the United States.  The DNP graduate understood the process of healthcare policymaking that 
can change based on the need for access to care, sensitive cultural need, and health disparity.  
Identification and stratification of the risk factors were steps to preventing ischemic stroke 
associated with AF.  The DNP student, designed, established, and implemented a quality 
improvement project in a clinic site that produced positive outcomes and helped improve the 
treatment and outcomes of AF patients.   Through collaboration with ECU faculty, the medical 
director, a physician assistant, nurse practitioners, nurses, and ancillary staff of the outpatient 
clinic, the DNP student executed the QI project with excellent outcomes.  The QI helped to 
achieve the requirements of the DNP competencies, and the national preventative care 
established by both government and organizations.  
IDENTIFYING STROKE RISK USING THE CHA2DS2-VASc 67 
 
 
Chapter Eight: Final Conclusions 
This chapter discussed the significant findings of this QI project as well as its strengths, 
weaknesses, limitations, and benefits.  It also delved into recommendations based on findings of 
the project.  A final summary provided closure to the paper. 
Significance of Findings  
 The outcome findings realized from the QI project included direct goals that had an 
immediate impact on the patients and the project site.  Direct goals included results that had a 
direct impact on the patients, project site, taxpayers, and health industry.  A significant outcome 
was the increased identification of the risk factors of AF patients and their risk stratification into 
low, moderate, or high levels.   The project found that 82% of AF patients screened in the clinic 
were stratified as moderate and high risk and would receive a recommendation for OAC for 
prevention of stroke.  Another significant outcome was the increased utilization of the evidence-
based practice risk assessment tool by the providers, which directly impacted the screening and 
stratification of patient's risks. The use of the CHA2DS2-VASc stratification tool was significant 
in increasing provider adherence to the clinical practice guidelines set by the American Heart 
Association, the American College of Cardiology, and the Heart Rhythm Society for AF patients.  
Adhering to clinical practice guidelines was purposeful in the effectiveness of quality care, 
decreasing variations in care, and in the reduction of preventable costly adverse events (Kredo, 
Bernhardsson, Machingaidze, Young, Louw, Ochodo, & Grimmer, 2016).   
The QI project led to the inclusion of the evidenced-based CHADS2-VASC risk 
stratification tool into the patient encounter in the electronic health record.  Being part of the 
template of a patient encounter in the clinic assured the sustainability of the project.  The reason 
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is that each patient encounter would ensure the assessment is completed for every AF patient, 
thereby improving efficiency in the identification of risk and care of the patient. 
The recommendation for OAC based on the moderate and high-risk levels of patient's 
risk identification is significant in the prevention of a thromboembolic event. With the 
prevention of an ischemic event, there is a subsequent reduction in the comorbidity associated 
with stroke.  It is significant in the sense that with the prevention of an ischemic event in AF 
patients, their quality of care and quality of life gets indirectly improved. 
Another significant outcome is the reduction of the financial burden associated with AF 
and stroke for the patients and taxpayers.  This outcome is in line with the adopted goals of the 
Triple Aim, which focuses on giving population and patient-centered care, risk status 
identification, and in decreasing the healthcare cost per capita (IHI, 2018).  With the prevention 
of an ischemic event with an OAC, a reduction in the financial burden for the taxpayer becomes 
substantial, considering that stroke costs about six million dollars for the taxpayer in the US 
yearly (Cutugno, 2015).  Furthermore, approximately 450,000 AF hospitalizations that occur 
each year in the US become significantly reduced when AF is prevented (Cutugno, 2015). 
The nurse practitioner care model is significant in this project.  This model was 
successfully developed and applied by advanced practice registered nurses (APRNs).  APRNs 
reduced costs and rehospitalization of cardiovascular patients. The framework was adopted in 
this project since there was a potential financial burden reduction for patients, healthcare 
industry, and taxpayers.  A lesson learned is that the application of the nurse practitioner care 
model to this QI at a micro-level produced a significant result; the same way, it will create a 
significant successful impact when applied at a macro level of project or research. 
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Project Strengths and Weaknesses 
          Strengths.  The strengths of this project include the use of an evidence-based risk 
stratification tool, CHA2DS2-VASc, to screen, stratify, and identify AF patient's stroke risks.  
The nurse practitioner care model provided strength for this QI in that the model identified risk 
factors, provided an intervention that will prevent stroke, and decreased costs to the patients and 
taxpayers.  The nursing model used in the project contributed strength to the project, without 
which it may be difficult to call the project a success.  The application of this impressive model 
in other primary care settings that currently have no standardized way of identifying AF patient’s 
risks will produce the same significant and beneficial health outcome 
 Electronic health records increased the ease of screening and risk identification.  EHR 
also increased the ease of chart reviews.  With login ID and password, the DNP student was able 
to have easy access to the project site to the patient's records in the E-clinical system. 
 Interprofessional collaboration between the DNP student, the faculty, and the project site 
providers, made the QI project a success.  A low-cost budget of the QI project is another strength 
for this project because it allowed for the DNP student to work within the allotted cost of the 
project and achieve the intended outcome. Another strength was faculty guidance throughout the 
writing of the paper and the conduction of the project.   
 ECU College of Nursing (CON) lead faculty, who guided the writing and implementation 
of the project for four semesters, was an excellent strength to this project.  The ECU CON lead 
faculty included academic guidance in the writing of this project.   
Weaknesses.  Weaknesses included time constraints in completing the project within 
three months of implementation of the project, which, if more time were available, more patients 
would screen for a more favorable result. 




Limitations included personnel shortage during the post-implementation survey.  It was 
challenging to reach one of the participants to collect post-implementation answers to project-
specific-questions. This limitation affected the use of all the questions in the survey (see 
Appendix N).  The QI project had limitations in office space at the project site during chart 
reviews of patient EHR and the collection of post-implementation data due to office space shared 
with staff, student interns, and students on clinical rotation.  This limitation from office space 
was overcome by doing chart reviews on the day interns, and students on rotation were not 
present in the clinic.  Another option was doing chart reviews towards the end of the day with 
less traffic in the office.    
Project Benefits 
          This project benefitted the patient by improving their care outcome.  When the patient's 
risks are identified and stratified, an OAC is recommended for use to prevent patients from 
suffering a stroke. Stroke prevention indirectly improves the quality of care received by the 
patients.  Further, the quality of life of the patient is also indirectly and positively impacted.   
Stroke prevention helps to reduce comorbidity and mortality associated with AF and stroke. This 
project is beneficial to the project site, and to other primary care clinics that have no standardized 
method of identifying AF risk factors A duplication of the project could produce the same result 
for them.  The taxpayers, healthcare industry, and patients benefit from this project due to a 
reduction in the financial and debilitating cost of AF and stroke.  This project potentially saved 
approximately 574,000 dollars for the patients in the project site and the taxpayers, considering 
that it costs about $14,000 per one stroke admission.  Out of the 50 patients screened, 41 patients 
scored moderate and high levels of risks.   




          Based on the significance, benefits, findings, limitations, strengths, and weaknesses of the 
project, the recommendation was for the project to be used and sustained.  Another 
recommendation was for a duplication of the project in other primary care clinics that do not 
have a standardized method of identification of AF patient's risks to benefit the patients, 
taxpayers, and clinics.  A replication of this project can be done in other primary care clinics to 
screen and identify more patient's risks and to recommend for OAC to prevent stroke.   
         Further guidance is for the project to evolve into research work with more time in order to 
ascertain proper OAC treatment options.  The involvement of human subjects is beyond the 
scope of this QI project.  However, further QI and research projects conducted can produce the 
results that impacts the reduction of stroke, improve the quality of care and life of AF patients, 
save patient's lives, and impact reduction of the financial burden associated with stroke in AF 
patients.   
Final Summary 
         This QI project provided increased identification and stratification of AF patient's stroke 
risk by utilizing an evidence-based risk assessment tool CHA2DS2-VASc. This paper discussed 
the identification of risks and recommendations for the treatment of AF with OAC to prevent 
stroke.  The strengths of the project enhanced the completion of the project to get the desired 
outcome goals. The QI project assisted with indirectly improving the care quality given to the 
patient.  The QI also indirectly improved the quality of life of the patients, saving healthcare 
costs, and advanced health education.  The weaknesses of the QI include a lack of understanding 
of the stratification process, lack of knowledge of how to use the screening tool as well as wrong 
stratification. Other flaws included limited office space experienced by the APRN student at the 
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project site during the implementation period.  Time constraints in conducting the 
implementation of the project were weakening to the project, considering that the DNP student 
had three months to prepare, educate, and execute the project.  
          The patients benefited from the project by directly having their risks identified, which 
helped to prevent stroke.  The patients also benefitted from the project by receiving good care 
quality and better quality of life due to stroke prevention.  The patient received health care cost 
reduction in hospital copayments, medication copayments, family care costs associated with a 
thromboembolic event.  The project site indirectly benefitted through indirect cost reduction to 
their patients and directly through reduced care cost in personnel for the patients who would 
have been stroke patients.  The project site benefitted from the collaboration with ECU College 
of Nursing, and the exposure received.  Benefits include increased provider adherence to the use 
of evidence-based guidelines for AF patients.  The taxpayers and healthcare industry benefited 
from the QI based on findings of the calculated amount of $574,000 dollars saved, potentially 
preventing stroke in the moderate and high-risk patients.  
          Overall, the project was a success considering that many advantages came from 
identifying and stratifying risk that prevented stroke in AF patients.  Fifty patients were screened 
for stroke risk, and 82% of the patients identified as the moderate to high-risk level. This project 
can be adopted and continued as a QI project in other primary care clinics that have no 
standardized method of screening and identifying stroke risk.  The same results, as described 
above, can be produced if duplicated for AF patients.  Further research is needed to determine 
the appropriate treatment options for patients receiving oral anticoagulation therapy.   
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ECU DNP Project Budget 
ECU DNP PROJECT EXPENSES
unit price Quantity  amount NOTES
Transportation - Gas to and fro.$10 per trip 12 Site Visits  120$          Cost of transportation per trip is $10. 
-                             
Snack food basket $30 per basket 6                        180$          Snack food for the staff
     
Grammerly   App $65 Copyright App 1                        60$            APP Subscritpion and Download for One Year
Copying & Printing 20 Cents per page 250 copies 50$            
Copeis of DNPI Eval, paper, Tools, Folder Jacket, $20 saved
from using cheaper copy center
CONTINGENCY  70$            for higher prices/cost of transportation, accomodation, food
LABOR - STAFF COST  No cost for my research/class time
Savings of $20 20.00$       Saved from Using Cheaper Copy Center
















IRB Approval Process 
Quality Improvement/Program Evaluation Self-Certification Tool 
Purpose: 
Projects that do not meet the federal definition of human research pursuant to 45 CFR 46 do not 
require IRB review. This tool was developed to assist in the determination of when a project 
falls outside of the IRB's purview. 
 
Instructions: 
Please complete the requested project information, as this document may be used for 
documentation that IRB review is not required. Select the appropriate answers to each question 
in the order they appear below. Additional questions may appear based on your answers. If you 
do not receive a STOP HERE message, the form may be printed as certification that the project 
is "not research," and does not require IRB review. The IRB will not review your responses as 
part of the self-certification process. 
 
Name of Project Leader: Chika Nwanedo 
Project Title:  Using the CHA2DS2-VASc Risk Score to Reduce Stroke: A quality improvement 
project 
Brief description of Project/Goals: 
The purpose of this Doctor of Nursing Practice (DNP) quality improvement (QI) project is to 
utilize the CHA2DS2-VASc screening tool to identify atrial fibrillation patients who are at low, 
moderate, or high risk for stroke and embolic disease in a Southeast NC Primary Health Care 
outpatient setting. Atrial Fibrillation (AF) is a significant risk factor for ischemic stroke and 
other thromboembolic events. AF puts patients at increased risk of arterial thromboembolism 
and ischemic stroke. About 90 percent of the patient population in the Southeast NC primary 
health care are adults. These patients may be at risk for stroke due to undetected atrial fibrillation 
(AF), yet, there is no standardized screening process or tool used to identify the patients who 
have AF. 
For this reason, a quality improvement project using the evidenced-based screening tool 
CHA2DS2-VASc will identify patients with AF at the primary care clinic. Patients will be 
stratified to low, moderate and high risk for stroke and embolic disease, for intervention with 
anticoagulation therapy following the American Heart Association (AHA)/American College of 
Cardiology (ACC)/Heart Rhythm Society (HRS) guidelines. Patients with AF have the most 
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common disorder of the cardiac rhythm. Based on Virchow’s Triad, AF causes stasis of blood in 
the heart, which increases the risk of arterial thromboembolism and stroke five-fold. Research 
shows that AF contributes to at least 15 percent of all strokes. The Center for Disease Control 
and Prevention approximates that 2.7 to 6.1 million people in the United States have AF. About 
2% of people younger than age 65 have AF, while about 9% of people aged 65 years or older 
have AF. With increased aging of the U.S. population, this number is expected to increase. The 
project will directly impact outpatient health care at a primary family practice by preventing 
strokes and achieving high-quality care outcomes for the AF patient population. The quality 
improvement project will be implemented in the Fall of 2019. The plan is to conduct two 
educational training on the use of the evidenced-based CHA2DS2VASc screening tool. The 
training will be done one week apart to cover all shifts. The training will focus on the use of the 
evidenced-based tool CHA2DS2-VASc to screen and identify patients with AF based on the 
CHA2DS2-VASc. Patients will be stratified to low, moderate, and high risks. With more than 
low risk, oral anticoagulation or antiplatelet therapy for the prevention of stroke or 
thromboembolism may be imperative. The first training will be done before the beginning of the 
implementation. Stratified data will be collected and evaluated after one week of screening 
patients with the CHA2DS2-VASc tool to ascertain the proper use of the instrument. A re-
education will be done at this stage to cover all staff and if the evaluation indicates the need for 
previously trained staff. Implementation will be for 60 days. Close weekly surveillance will be 
conducted on the use of the screening tool and for data collection. The project implementations 
will be evaluated using a Plan-Do-Study-Act (PDSA) model. Measurable objectives include the 
number of electronic patient records indicating the use and application of the QI project 
screening tool. 
Further measurable objective is how many patients identified to need a recommendation for 
anticoagulation therapy based on the CHA2DS2-VASc project and guideline. The project will, 
through education of the staff and standard practice, sustain itself. The QI, though begins at a 
micro level, is expected to extend to a macro clinical practice level and thus provide a foundation 
for future interprofessional leadership. 
Based on your responses, the project appears to constitute QI and Program Evaluation. IRB 
review is not required because, in accordance with federal regulations, your project does not 
constitute research as defined under 45 CFR 46.102(d). If the project results are disseminated, 
they should be characterized as QI and/or Program Evaluation findings. Finally, if the project 
changes in any way that might affect the intent or design, please complete this self-certification 
again to ensure that IRB review is still not required. Click the button below to view a printable 
version of this form to save with your files, as it serves as documentation that IRB review is not 
required for this project.  6/21/2019.  Powered by Qualtrics 
 
 





Demographic and Project-Specific Question for Participants 
Questionnaire  
Using the CHA2DS2-VASc Risk Score to Reduce Stroke: A quality improvement project  
1.  Are you an employee of this clinic?   _______Yes  No______ 
2. What is your gender? Male______, Female_____ 
3. What is your position? ______ 
4. How Long have you worked in this clinic?  Less than 1 – 4years______,   
  5years -10 years _______, 11years – 15years _______, 16years – 20years______,  
 21years – 25years _______, 26 years and above ______ 
5.  Are you supportive of using the CHA2DS2-VASC to screen patients?  Yes_____, No_____   
6. Do you believe that the screening will increase quality care and save lives? Yes_____, No_____   
7. Do you believe that the screening tool will bring some changes in the clinic  
e.g. patient satisfaction, extra work for staff? Yes______, No______ 
8.  Do you believe that such change from using CHAD2s2-VASc will improve patient  outcome?  
9. How likely are you to use the screening tool CHA2DS2-VASc?  Not at all Likely_____,  
Somewhat likely _____, Neither Likely nor Likely _____,  very Likely _____ 
10. Are you ready for the change that the screening tool will bring? Yes_____, No _____  
INSTRUCTIONS TO SURVEY PARTICIPANTS IN QI PROJECT 
• This survey is given for collection of data for a quality Improvement projects 
• Please read and answer all questions and provide your answers in the spaces given. 












DNP Poster Presentation 
 
• 15% of ischemic strokes in the US are caused 
by atrial fibrillation (AF)
• No standardized method of identification 
of stroke risk in AF patients ≥65 years 
• Debilitating health and financial burden on 
patients, healthcare and taxpayers
• Educate providers on use of tool
• Providers screened patients with risk 
assessment tool CHA2DS2-VASc
• Risk stratify AF patient for stroke
• Nurse Practitioner Care Model as framework 
• Interprofessional collaboration 
• SWOT Analysis and PDSA
• Track screening
• Increased screening as part of patient EHR
• Improved quality of care, decreased health 
costs
• Sustainability- increased adherence to use 
of CHA2DS2-VASc tool 
• Increased screening and identification for 
recommendation of therapeutic 
intervention
• Improved provider’s adherence to clinical 
guidelines for AF 
• N=50, 82% screened patients met eligibility 
for recommendation for oral 
anticoagulation therapy based on 





Increasing Identification of Stroke Risk in Atrial Fibrillation Patients
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To increase identification of stroke risk in AF 







Stratification of Identified Risks
Low Risk 0-1 Moderate Risk 2-4 High Risk 5-9
N=50, 82% screened met eligibility for OAC
 
